Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026)
Bausch Health Companies (BHC) posted Goodwill & Intangibles of $14.0 billion for Q2 2026, down 1.68% sequentially from $14.2 billion in Q1 2026, and down 14.52% YoY from $16.3 billion in Q2 2025.
Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Goodwill & Intangibles for 18 years, with the latest figure at $14.0 billion in Q2 2026.
- Quarterly Goodwill & Intangibles fell 14.52% year-over-year to $14.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.0 billion (down 14.52% YoY) and the FY2025 annual result came in at $15.9 billion, down 4.35% from the prior year.
- Goodwill & Intangibles fell to $14.0 billion in Q2 2026 per BHC's latest filing, from $14.2 billion in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $19.1 billion in Q1 2022 and troughed at $6.5 billion in Q3 2022.
- A 5-year average of $15.7 billion and a median of $16.7 billion in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles sank 67.04% in 2022, then soared 112.41% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $17.3 billion in 2022, then grew by 1.68% to $17.6 billion in 2023, then fell by 5.67% to $16.6 billion in 2024, then declined by 4.35% to $15.9 billion in 2025, then retreated by 12.2% to $14.0 billion in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $14.0 billion, $14.2 billion, and $15.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.97 Bn |
| Mar 31, 2026 | 14.21 Bn |
| Dec 31, 2025 | 15.91 Bn |
| Sep 30, 2025 | 16.12 Bn |
| Jun 30, 2025 | 16.35 Bn |
| Mar 31, 2025 | 16.45 Bn |
| Dec 31, 2024 | 16.64 Bn |
| Sep 30, 2024 | 16.82 Bn |
| Jun 30, 2024 | 17.03 Bn |
| Mar 31, 2024 | 17.34 Bn |
| Dec 31, 2023 | 17.64 Bn |
| Sep 30, 2023 | 7.92 Bn |
| Jun 30, 2023 | 16.93 Bn |
| Mar 31, 2023 | 17.13 Bn |
| Dec 31, 2022 | 17.35 Bn |
| Sep 30, 2022 | 6.50 Bn |
| Jun 30, 2022 | 18.59 Bn |
| Mar 31, 2022 | 19.06 Bn |
| Dec 31, 2021 | 19.41 Bn |
| Sep 30, 2021 | 19.74 Bn |